Search

You searched for "care"

739 results found
Journal of Clinical Urology front cover image with Editor's Choice stamp.

Malignant upper urinary tract obstruction: emergency presentations and long-term outcomes

2 July 2025 | | URO - Urologic Oncology, URO - Trauma & Emergency
Malignant upper urinary tract obstruction (MUUTO) is a frequent emergency urological referral, often necessitating kidney drainage to preserve renal function. However, many patients have advanced cancer with limited life expectancy, raising questions about intervention benefits. While percutaneous nephrostomy (PCN) or...

New analysis by Prostate Cancer UK uncovers inequalities in mortality and refutes prevailing beliefs

13 November 2025
Prostate cancer mortality rates continue to be higher in Black men than white men, latest analysis reports. The disparity persists across all levels of deprivation, challenging beliefs that socioeconomic differences alone explain ethnic differences in outcomes. Even in the least...

Post radical nephrectomy presenting with skull metastasis

10 April 2024 | | URO - Urologic Oncology
We present the case of an 83-year-old female who underwent right radical nephrectomy for renal cell carcinoma (RCC). Despite negative surgical margins, the patient presented with a skull metastasis six years post radical nephrectomy. This case highlights the importance of...

Can we make LATE-presenting posterior urethral valves an EARLIER-treated condition?

3 September 2024 | | URO - Paediatrics
What are posterior urethral valves? Posterior urethral valve (PUV) is the most common cause of congenital bladder outlet obstruction (BOO) and renal failure in male children. They were first described by the Italian anatomist Giovanni Battista Morgagni back in the...

Clinical Trials 2 – key papers

1 March 2017 | URO - Basic Science Research
Clinical Trials 1 is available here. Case 1 This British study on haematuria clinic diagnostic yield was published in the British Journal of Urology International in 2006. The results are often asked in examinations! Edwards TJ, et al. A prospective...

Renal masses

2 March 2022 | | URO - Urologic Oncology
Case 1 A 70-year-old female presented under the medical team with malaise, weight loss, and deranged liver function tests (LFTs) and calcium (ALP 350, GGT 650, Serum bilirubin 29, normal aminotransferases, Ca 3.3). An abdominal ultrasound scan (USS) was performed...

In conversation with Mr Duncan Summerton

1 November 2018 | URO - Core Urology
Urology News was delighted to recently have a chat with Duncan Summerton, Consultant Urological Surgeon in Leicester and new President of BAUS. Duncan with a native wild brown trout caught on a dry fly on the Derbyshire Wye. Can you...

Nurse practitioner TRUS biopsy: training and preparation

1 May 2014 | | URO - Urologic Oncology
As prostate cancer rates increase, many urology departments rely on multi-professional teams to diagnose and manage patients with prostate cancer. The aim of this article is to highlight the skills, training and preparation required for nurse practitioners to undertake trans-rectal...

Penile Mondor’s disease

1 January 2019 | | URO - Andrology
Mondor’s disease is a rare, self-limiting entity characterised by subcutaneous chord like bands throughout the body. These bands arise due to phlebitis of the subcutaneous vessels. Penile Mondor’s disease (PMD) is an isolated superficial thrombophlebitis of the superficial dorsal vein...

Stereotactic body radiotherapy for oligometastatic disease secondary to urological cancer

1 January 2016 | | URO - Urologic Oncology, URO - Technology
The concept of oligometastatic disease is controversial. The traditional model of cancer, which most of us learnt at medical school, is of a disease which starts confined to an organ, for example the prostate, where it can be cured with...

Demanding cases or nightmares in endourology? May/Jun 2016

1 May 2016 | | URO - Endourology & Stones
In the third article in this series the authors describe their experience with the very rare indications for laparoscopic stone surgery. Case 1 A 44-year-old woman presented with several months of malaise and right flank pain. A CT scan demonstrated...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...